Annual revenue:
$203.07M+$39.16M(+23.89%)Summary
- As of today (June 24, 2025), XERS annual revenue is $203.07 million, with the most recent change of +$39.16 million (+23.89%) on December 31, 2024.
- During the last 3 years, XERS annual revenue has risen by +$153.48 million (+309.50%).
- XERS annual revenue is now at all-time high.
Performance
XERS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$60.12M+$20.00K(+0.03%)Summary
- As of today (June 24, 2025), XERS quarterly revenue is $60.12 million, with the most recent change of +$20.00 thousand (+0.03%) on March 1, 2025.
- Over the past year, XERS quarterly revenue has increased by +$19.48 million (+47.94%).
- XERS quarterly revenue is now at all-time high.
Performance
XERS Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$222.55M+$19.48M(+9.59%)Summary
- As of today (June 24, 2025), XERS TTM revenue is $222.55 million, with the most recent change of +$19.48 million (+9.59%) on March 1, 2025.
- Over the past year, XERS TTM revenue has increased by +$51.20 million (+29.88%).
- XERS TTM revenue is now at all-time high.
Performance
XERS TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
XERS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.9% | +47.9% | +29.9% |
| 3 y3 years | +309.5% | +172.4% | +250.7% |
| 5 y5 years | +7360.3% | +3487.1% | +5262.7% |
XERS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +309.5% | at high | +172.4% | at high | +250.7% |
| 5 y | 5-year | at high | +7360.3% | at high | +3487.1% | at high | +5262.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
XERS Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $60.12M(+0.0%) | $222.55M(+9.6%) |
| Dec 2024 | $203.07M(+23.9%) | $60.10M(+10.7%) | $203.07M(+8.4%) |
| Sep 2024 | - | $54.27M(+12.9%) | $187.36M(+3.3%) |
| Jun 2024 | - | $48.06M(+18.3%) | $181.41M(+5.9%) |
| Mar 2024 | - | $40.64M(-8.5%) | $171.36M(+4.5%) |
| Dec 2023 | $163.91M(+48.7%) | $44.39M(-8.1%) | $163.91M(+7.4%) |
| Sep 2023 | - | $48.32M(+27.1%) | $152.67M(+13.9%) |
| Jun 2023 | - | $38.01M(+14.5%) | $134.07M(+10.5%) |
| Mar 2023 | - | $33.20M(+0.2%) | $121.37M(+10.1%) |
| Dec 2022 | $110.25M(+122.3%) | $33.14M(+11.5%) | $110.25M(+11.9%) |
| Sep 2022 | - | $29.73M(+17.5%) | $98.53M(+23.4%) |
| Jun 2022 | - | $25.31M(+14.6%) | $79.87M(+25.8%) |
| Mar 2022 | - | $22.07M(+3.0%) | $63.47M(+28.0%) |
| Dec 2021 | $49.59M(+142.7%) | $21.43M(+93.8%) | $49.59M(+39.6%) |
| Sep 2021 | - | $11.06M(+24.2%) | $35.53M(+4.9%) |
| Jun 2021 | - | $8.91M(+8.7%) | $33.87M(+25.5%) |
| Mar 2021 | - | $8.20M(+11.2%) | $27.00M(+31.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $20.43M(+650.7%) | $7.37M(-21.6%) | $20.48M(+36.8%) |
| Sep 2020 | - | $9.40M(+363.9%) | $14.97M(+154.6%) |
| Jun 2020 | - | $2.03M(+20.9%) | $5.88M(+41.7%) |
| Mar 2020 | - | $1.68M(-10.1%) | $4.15M(+52.5%) |
| Dec 2019 | $2.72M(+12.3%) | $1.86M(+495.5%) | $2.72M(+68.3%) |
| Sep 2019 | - | $313.00K(+5.4%) | $1.62M(-14.3%) |
| Jun 2019 | - | $297.00K(+19.8%) | $1.89M(-21.7%) |
| Mar 2019 | - | $248.00K(-67.3%) | $2.41M(-0.6%) |
| Dec 2018 | $2.42M(+55.7%) | $759.00K(+30.4%) | $2.42M(+13.7%) |
| Sep 2018 | - | $582.00K(-28.9%) | $2.13M(+24.0%) |
| Jun 2018 | - | $819.00K(+211.4%) | $1.72M(+17.3%) |
| Mar 2018 | - | $263.00K(-43.7%) | $1.47M(-5.8%) |
| Dec 2017 | $1.56M(+44.7%) | $467.00K(+174.7%) | $1.56M(+42.9%) |
| Sep 2017 | - | $170.00K(-69.9%) | $1.09M(+18.5%) |
| Jun 2017 | - | $565.00K(+59.6%) | $919.00K(+159.6%) |
| Mar 2017 | - | $354.00K | $354.00K |
| Dec 2016 | $1.07M | - | - |
FAQ
- What is Xeris Biopharma Holdings annual revenue?
- What is the all time high annual revenue for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual revenue year-on-year change?
- What is Xeris Biopharma Holdings quarterly revenue?
- What is the all time high quarterly revenue for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly revenue year-on-year change?
- What is Xeris Biopharma Holdings TTM revenue?
- What is the all time high TTM revenue for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings TTM revenue year-on-year change?
What is Xeris Biopharma Holdings annual revenue?
The current annual revenue of XERS is $203.07M
What is the all time high annual revenue for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual revenue is $203.07M
What is Xeris Biopharma Holdings annual revenue year-on-year change?
Over the past year, XERS annual revenue has changed by +$39.16M (+23.89%)
What is Xeris Biopharma Holdings quarterly revenue?
The current quarterly revenue of XERS is $60.12M
What is the all time high quarterly revenue for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly revenue is $60.12M
What is Xeris Biopharma Holdings quarterly revenue year-on-year change?
Over the past year, XERS quarterly revenue has changed by +$19.48M (+47.94%)
What is Xeris Biopharma Holdings TTM revenue?
The current TTM revenue of XERS is $222.55M
What is the all time high TTM revenue for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high TTM revenue is $222.55M
What is Xeris Biopharma Holdings TTM revenue year-on-year change?
Over the past year, XERS TTM revenue has changed by +$51.20M (+29.88%)